Loading stock chart…

Scinai Immunotherapeutics Ltd. (SCNI)

Historical prices through 2026-10-08Latest fiscal period 2022-12-31

Price & fundamentals

Export data/plot:

Timeframe

Compound Annual Growth Rate(CAGR)

—Drag a handle to resize, or the inner selected area to move all five windows—

Detailed metric definitions →

Historical valuation multiples

Export data/plot:

Timeframe

Show P/E 15× / 20× / 30× reference lines

Drag a handle to resize, or the inner selected area to move all five windows

Detailed metric definitions →

Ratio observations in the selected window

Price date	EPS fiscal end	Basic P/E (×)	Diluted P/E (×)	P/S (×)	P/FCF (×)

Profit margins

Export data/plot:

Timeframe

Drag a handle to resize, or the inner selected area to move all five windows

Calculation inputs, filings & unavailable observations

Detailed metric definitions →

Yield, cash conversion & capital returns

Export data/plot:

Timeframe

Drag a handle to resize, or the inner selected area to move all five windows

Calculation inputs, filings & unavailable observations

Detailed metric definitions →

Price & growth-based reference

Export data/plot:

Compound Annual Growth Rate (CAGR)—Selected window

Growth-based P/E—

Formula: min(60, 15 × ((1 + CAGR / 100) / 1.10)^{years × 0.6})

Timeframe

Drag a handle to resize, or the inner selected area to move all five windows

Detailed metric definitions →

Annual change in the selected reference metric

YEAR-OVER-YEAR

Annual metric change

Change from the previous reported fiscal year

Increase Decrease

Annual data and sources

Scinai Immunotherapeutics Ltd. (SCNI) · Nasdaq · USD · Sector unavailable · CIK 0001611747

Annual coverage: 2021-12-31–2022-12-31 (2 periods). Financial snapshot built 2026-10-09.

SCNI annual financial history

All stored annual observations, independent of the chart window. Per-share amounts in USD. Unavailable values are not zero.

See the calculation and limitations.

Annual EPS, cash flow, dividends, and fiscal-year dividend yield for Scinai Immunotherapeutics Ltd.
Fiscal year / end	Basic EPS	Diluted EPS	FCF / share	Dividends / share	Fiscal-year dividend yield	Filing sources
2022 2022-12-31	-0.01	-0.01	-0.01	Unavailable	Unavailable	Basic EPS (2023-04-17) Diluted EPS (2023-04-17) Operating cash flow (2023-04-17) · Capex (2023-04-17)
2021 2021-12-31	-0.02	-0.02	-0.01	Unavailable	Unavailable	Basic EPS (2023-04-17) Diluted EPS (2023-04-17) Operating cash flow (2023-04-17) · Capex (2023-04-17)

Annual per-share context (USD/share)

Complete annual history, independent of chart loading and range. Revenue/share is annual revenue per average diluted share. Debt/share is borrowings per year-end common share, excluding leases. Missing inputs remain unavailable. Metric definitions.

Fiscal end	Revenue / share	Total debt / share	Inputs & filing sources
2022-12-31	Unavailable	Unavailable	Inputs & filings revenue: No unambiguous matching annual USD fact; averageDilutedShares: 754076407; totalDebt: No supported complete debt aggregate or non-overlapping borrowing components; leases excluded; periodEndShares: 989290784 averageDilutedShares (2023-04-17) periodEndShares (2023-04-17)
2021-12-31	Unavailable	Unavailable	Inputs & filings revenue: No unambiguous matching annual USD fact; averageDilutedShares: 564575967; totalDebt: No supported complete debt aggregate or non-overlapping borrowing components; leases excluded; periodEndShares: 739048544 averageDilutedShares (2023-04-17) periodEndShares (2023-04-17)

Annual returns and cash generation (%)

Complete annual history, independent of chart loading and range. FCF margin and FCF / net income use matching annual totals. ROCE uses positive exact opening and closing capital-employed bases. Inputs, scopes and unavailable reasons are disclosed below. Missing inputs remain unavailable. Metric definitions.

Fiscal end	FCF margin (%)	FCF / net income (%)	ROCE (%)	Inputs & filing sources
2022-12-31	Unavailable	Unavailable	-40.72	Inputs & filings Calculation inputs: {"original":{"fcfTotal":{"value":-8101000,"capex":{"accession":"0001213900-23-030228","end":"2022-12-31","filed":"2023-04-17","form":"10-K","start":"2022-01-01","tag":"PaymentsToAcquirePropertyPlantAndEquipment","unit":"USD"},"ocf":{"accession":"0001213900-23-030228","end":"2022-12-31","filed":"2023-04-17","form":"10-K","start":"2022-01-01","tag":"NetCashProvidedByUsedInOperatingActivities","unit":"USD"}},"revenue":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"netIncome":{"value":-5796000,"tag":"NetIncomeLoss","unit":"USD","start":"2022-01-01","end":"2022-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"operatingIncome":{"value":-11061000,"tag":"OperatingIncomeLoss","unit":"USD","start":"2022-01-01","end":"2022-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"openingAssets":{"value":32036000,"tag":"Assets","unit":"USD","start":null,"end":"2021-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"openingCurrentLiabilities":{"value":2444000,"tag":"LiabilitiesCurrent","unit":"USD","start":null,"end":"2021-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"openingCapitalEmployed":{"value":29592000,"inputNames":["openingAssets","openingCurrentLiabilities"]},"openingParentEquity":{"value":982000,"tag":"StockholdersEquity","unit":"USD","start":null,"end":"2021-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"openingTotalEquity":{"value":982000,"tag":"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest","unit":"USD","start":null,"end":"2021-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"openingCash":{"value":17374000,"tag":"CashAndCashEquivalentsAtCarryingValue","unit":"USD","start":null,"end":"2021-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"openingBorrowings":{"value":null,"reason":"No supported complete debt aggregate or non-overlapping borrowing components; leases excluded"},"openingInvestedCapital":{"value":null,"inputNames":["openingBorrowings","openingTotalEquity","openingCash"],"reason":"Exact complete borrowings, consolidated equity and cash missing, ambiguous or from different filings at 2021-12-31"},"openingPreferredEquity":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"openingPreferredShares":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"openingCommonEquity":{"value":null,"inputNames":["openingParentEquity","openingPreferredShares"],"reason":"Common equity scope requires explicit preferred carrying value or zero preferred shares; absence is not zero"},"closingAssets":{"value":27067000,"tag":"Assets","unit":"USD","start":null,"end":"2022-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"closingCurrentLiabilities":{"value":2338000,"tag":"LiabilitiesCurrent","unit":"USD","start":null,"end":"2022-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"closingCapitalEmployed":{"value":24729000,"inputNames":["closingAssets","closingCurrentLiabilities"]},"closingParentEquity":{"value":-1760000,"tag":"StockholdersEquity","unit":"USD","start":null,"end":"2022-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"closingTotalEquity":{"value":-1760000,"tag":"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest","unit":"USD","start":null,"end":"2022-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"closingCash":{"value":14075000,"tag":"CashAndCashEquivalentsAtCarryingValue","unit":"USD","start":null,"end":"2022-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"closingBorrowings":{"value":null,"reason":"No supported complete debt aggregate or non-overlapping borrowing components; leases excluded"},"closingInvestedCapital":{"value":null,"inputNames":["closingBorrowings","closingTotalEquity","closingCash"],"reason":"Exact complete borrowings, consolidated equity and cash missing, ambiguous or from different filings at 2022-12-31"},"closingPreferredEquity":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"closingPreferredShares":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"closingCommonEquity":{"value":null,"inputNames":["closingParentEquity","closingPreferredShares"],"reason":"Common equity scope requires explicit preferred carrying value or zero preferred shares; absence is not zero"},"commonNetIncome":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"parentNetIncome":{"value":-5796000,"tag":"NetIncomeLoss","unit":"USD","start":"2022-01-01","end":"2022-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"preferredDividends":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"incomeTaxExpense":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"pretaxIncome":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"effectiveTaxRate":{"value":null,"inputNames":["incomeTaxExpense","pretaxIncome"],"reason":"Matching annual income-tax expense or supported pretax income unavailable"},"nopat":{"value":null,"inputNames":["operatingIncome","effectiveTaxRate"],"reason":"Matching annual income-tax expense or supported pretax income unavailable"},"averageInvestedCapital":{"value":null,"inputNames":["openingInvestedCapital","closingInvestedCapital"]},"averageCapitalEmployed":{"value":27160500,"inputNames":["openingCapitalEmployed","closingCapitalEmployed"]},"averageCommonEquity":{"value":null,"inputNames":["openingCommonEquity","closingCommonEquity"]}},"recovered":{}}; fcfMargin: No unambiguous matching annual USD fact; cashConversion: Positive net income required; zero or negative denominator is unavailable; roce: -40.724581653504174 fcfMargin component 1 (2023-04-17) · fcfMargin component 2 (2023-04-17) cashConversion component 1 (2023-04-17) · cashConversion component 2 (2023-04-17) · cashConversion component 3 (2023-04-17) roce component 1 (2023-04-17) · roce component 2 (2023-04-17) · roce component 3 (2023-04-17) · roce component 4 (2023-04-17) · roce component 5 (2023-04-17)
2021-12-31	Unavailable	Unavailable	Unavailable	Inputs & filings Calculation inputs: {"original":{"fcfTotal":{"value":-7565000,"capex":{"accession":"0001213900-23-030228","end":"2021-12-31","filed":"2023-04-17","form":"10-K","start":"2021-01-01","tag":"PaymentsToAcquirePropertyPlantAndEquipment","unit":"USD"},"ocf":{"accession":"0001213900-23-030228","end":"2021-12-31","filed":"2023-04-17","form":"10-K","start":"2021-01-01","tag":"NetCashProvidedByUsedInOperatingActivities","unit":"USD"}},"revenue":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"netIncome":{"value":-8206000,"tag":"NetIncomeLoss","unit":"USD","start":"2021-01-01","end":"2021-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"operatingIncome":{"value":-10862000,"tag":"OperatingIncomeLoss","unit":"USD","start":"2021-01-01","end":"2021-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"openingAssets":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"openingCurrentLiabilities":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"openingCapitalEmployed":{"value":null,"inputNames":["openingAssets","openingCurrentLiabilities"],"reason":"Exact assets/current-liabilities balance missing, conflicting or from different filings at 2020-12-31"},"openingParentEquity":{"value":-15038000,"tag":"StockholdersEquity","unit":"USD","start":null,"end":"2020-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"openingTotalEquity":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"openingNoncontrollingEquity":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"openingLiabilities":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"openingCash":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"openingBorrowings":{"value":null,"reason":"No supported complete debt aggregate or non-overlapping borrowing components; leases excluded"},"openingInvestedCapital":{"value":null,"inputNames":["openingBorrowings","openingTotalEquity","openingCash"],"reason":"Exact complete borrowings, consolidated equity and cash missing, ambiguous or from different filings at 2020-12-31"},"openingPreferredEquity":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"openingPreferredShares":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"openingCommonEquity":{"value":null,"inputNames":["openingParentEquity","openingPreferredShares"],"reason":"Common equity scope requires explicit preferred carrying value or zero preferred shares; absence is not zero"},"closingAssets":{"value":32036000,"tag":"Assets","unit":"USD","start":null,"end":"2021-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"closingCurrentLiabilities":{"value":2444000,"tag":"LiabilitiesCurrent","unit":"USD","start":null,"end":"2021-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"closingCapitalEmployed":{"value":29592000,"inputNames":["closingAssets","closingCurrentLiabilities"]},"closingParentEquity":{"value":982000,"tag":"StockholdersEquity","unit":"USD","start":null,"end":"2021-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"closingTotalEquity":{"value":982000,"tag":"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest","unit":"USD","start":null,"end":"2021-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"closingCash":{"value":17374000,"tag":"CashAndCashEquivalentsAtCarryingValue","unit":"USD","start":null,"end":"2021-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"closingBorrowings":{"value":null,"reason":"No supported complete debt aggregate or non-overlapping borrowing components; leases excluded"},"closingInvestedCapital":{"value":null,"inputNames":["closingBorrowings","closingTotalEquity","closingCash"],"reason":"Exact complete borrowings, consolidated equity and cash missing, ambiguous or from different filings at 2021-12-31"},"closingPreferredEquity":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"closingPreferredShares":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"closingCommonEquity":{"value":null,"inputNames":["closingParentEquity","closingPreferredShares"],"reason":"Common equity scope requires explicit preferred carrying value or zero preferred shares; absence is not zero"},"commonNetIncome":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"parentNetIncome":{"value":-8206000,"tag":"NetIncomeLoss","unit":"USD","start":"2021-01-01","end":"2021-12-31","filed":"2023-04-17","accession":"0001213900-23-030228","form":"10-K"},"preferredDividends":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"incomeTaxExpense":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"pretaxIncome":{"value":null,"reason":"Missing or conflicting matching SEC fact","conflict":false},"effectiveTaxRate":{"value":null,"inputNames":["incomeTaxExpense","pretaxIncome"],"reason":"Matching annual income-tax expense or supported pretax income unavailable"},"nopat":{"value":null,"inputNames":["operatingIncome","effectiveTaxRate"],"reason":"Matching annual income-tax expense or supported pretax income unavailable"},"averageInvestedCapital":{"value":null,"inputNames":["openingInvestedCapital","closingInvestedCapital"]},"averageCapitalEmployed":{"value":null,"inputNames":["openingCapitalEmployed","closingCapitalEmployed"]},"averageCommonEquity":{"value":null,"inputNames":["openingCommonEquity","closingCommonEquity"]}},"recovered":{}}; fcfMargin: No unambiguous matching annual USD fact; cashConversion: Positive net income required; zero or negative denominator is unavailable; roce: matching numerator and positive exact opening/closing CapitalEmployed required; ambiguous scopes remain unavailable; unavailable: openingCapitalEmployed; Exact assets/current-liabilities balance missing, conflicting or from different filings at 2020-12-31 fcfMargin component 1 (2023-04-17) · fcfMargin component 2 (2023-04-17) cashConversion component 1 (2023-04-17) · cashConversion component 2 (2023-04-17) · cashConversion component 3 (2023-04-17) roce component 1 (2023-04-17) · roce component 2 (2023-04-17) · roce component 3 (2023-04-17)

Annual operating facts

Complete annual history, independent of chart loading and range. Operating margin is operating profit as a percentage of revenue; net margin is consolidated net profit as a percentage of revenue. Negative margins show losses. Missing inputs remain unavailable. Metric definitions.

Fiscal end	Revenue (USD)	Operating margin (%)	Net margin (%)	Inputs & filing sources
2022-12-31	Unavailable	Unavailable	Unavailable	Inputs & filings revenue: No unambiguous matching annual USD fact; operatingIncome: -11061000; netIncome: -5796000 operatingIncome (2023-04-17) netIncome (2023-04-17)
2021-12-31	Unavailable	Unavailable	Unavailable	Inputs & filings revenue: No unambiguous matching annual USD fact; operatingIncome: -10862000; netIncome: -8206000 operatingIncome (2023-04-17) netIncome (2023-04-17)

Scinai Immunotherapeutics Ltd. (SCNI) P/E ratio history

The interactive P/E chart contains all 596 stored weekly price points (2015-05-15–2026-10-08); 0 have an eligible basic or diluted ratio. Annual EPS is carried forward from its fiscal end. Use the P/E range bar or any other chart range bar to change all five chart windows.

Fiscal-year-end snapshots

No positive annual EPS with an eligible fiscal-year-end price is available in this snapshot.

Annual P/E = eligible fiscal-year-end close ÷ reported annual EPS. This is retrospective annual P/E, not TTM or forward P/E. Why we use annual data. Missing or non-positive EPS and missing eligible prices produce unavailable ratios.

Explore the P/E chart and optional reference lines · How P/E history is calculated.

Complete annual P/E history (2 fiscal periods)

Full stored fiscal-year-end P/E history, independent of the selected chart window. Ratios in ×; prices in USD.
Fiscal end	Price date	Close	Price basis	Basic P/E	Diluted P/E	EPS filings
2022-12-31	2022-12-30	29.60	Adjusted close	Unavailable	Unavailable	Basic EPS (2023-04-17) Diluted EPS (2023-04-17)
2021-12-31	2021-12-31	235.00	Adjusted close	Unavailable	Unavailable	Basic EPS (2023-04-17) Diluted EPS (2023-04-17)

Did this research save you time?

I build and maintain Stock Value Lens independently. If you found it useful, a coffee helps me maintain the tools and improve data updates.

Buy me a coffee · €5